Johnson & Johnson’ company discontinues the Covid-19 vaccine trial

Washington : American-based Johnson & Johnson has temporarily discontinued its clinical trial of the Coronavirus vaccine.

The Johnson & Johnson Company said all dosing in the coronavirus vaccine trials would be temporarily stopped.
The third and final phase of the vaccine manufactured by the Johnson Company involved clinical testing of over 60,000 people. The company said the trial on humans was temporary because unexplained diseases were visible to those tested.

“The company has developed a single shot vaccine to prevent the person from getting infected once in a while. The clinical trial has been discontinued since 12th due to unexplained diseases visible to those who have undergone the vaccine. This vaccine trial was in phase three. A clinical trial was scheduled to take place until the end of December, Reuters news agency reported.